Guest guest Posted July 3, 2001 Report Share Posted July 3, 2001 From: " ilena rose " <ilena@...> Sent: Monday, July 02, 2001 7:27 PM Subject: Asbestos, Breast Implants, Tobacco & Other Tort-Plagued Manufacturers > ~~~PR team for the manufacturers posted this piece today~~~ > > EXCERPT: > > " He points to part of the Court's concluding statements in the Dow-Corning > case: > " The United States' Constitution and the rules and laws governing the judicial > system, although they may not be perfect, were enacted to ensure that all > parties' due process rights are observed by the courts. " > > Contact Allan Ripp, 212-721-7468, arippnyc@..., or Elena Napravnik, > 212-721-9979, elena73@... both for National Economic Research > Associates > > > > > Fred Dunbar, Senior NERA Economist, Provides Trial Expertise on Behalf of > Beleaguered Manufacturers Facing Plaintiff Class Actions > > > Expert in Trade Regulation, Mass Torts A Frequent Testifier in > > Controversial Cases > > Asbestos, Breast Implants, Tobacco & Other Tort-Plagued Manufacturers > > All in a Day's Work' > > NEW YORK, July 2 /PRNewswire/ -- Dr. Fred Dunbar, a senior economist with > National Economic Research Associates (NERA), is an expert in the economics of > antitrust and trade regulation, and risk management including mass torts and > claims estimation, securities and valuation, transportation. He is one of the > most frequently retained experts in the nation on mass torts, securities, and > antitrust litigation. Dr. Dunbar's work is often on behalf of controversial > manufacturers targeted by large class action lawsuits. > > Dr. Dunbar, who has testified dozens of times, is presently involved in > lawsuits against U.S. tobacco companies. The government has just announced > plans to move towards a settlement of its $20 billion tobacco lawsuit, a > decision that has received backlash by anti-smoking groups. > > In numerous cases, Dr. Dunbar's testimony has been cited as the influencing > factor in a court's decision. > > As a key participant in bankruptcy proceedings for Dow-Corning's highly > publicized breast implant case, one of the largest mass tort bankruptcy actions > ever filed in the U.S., he provided testimony forecasting the legal costs and > settlement values of future claims. In its decision, the court noted that it > was " very impressed " by Dr. Dunbar's estimates on the number of claimants who > would elect to settle and the average award for each claimant, which he arrived > at after careful study of prior proceedings. > > And this past month, Dr. Dunbar provided testimony on behalf of tobacco company > Santa Fe Natural, which helped overturn a New York statute banning the sale of > tobacco products through catalogues and the Internet. The statute was struck > down after U.S. District Court Judge Loretta A. Preska found that the statute > failed two key tests under the Commerce Clause. > > In a 76-page decision, issued in June, the judge cited Dr. Dunbar's testimony > as a key factor in showing that the state's justifications for the restrictive > actions, including prevention of tax evasion and youth smoking, would have > little effect. For example, she credited Dr. Dunbar testimony that " all a youth > has to do is go to five stores and the mathematics are they have gotten a 97 > percent chance of acquiring a pack of cigarettes, " noting " Dr. Dunbar's > testimony and conclusion to the effect that closing down sales channels will > not reduce smoking to any considerable degree. Accordingly, defendants have > not carried their burden of demonstrating that Section 1399-11 will effect any > material benefits. " > > Leveling the Playing Field for Controversial Manufacturers > > Highly charged issues such as public health concerns are catalysts for > commercial and political interests and can be used to skirt difficult legal and > political questions, Dr. Dunbar says. He believes that manufacturers of > products such as tobacco, breast implants, and asbestos, already subject to > negative public opinion, become " easy targets " in the legal system, from > restrictive legislation to mass lawsuits brought by entrepreneurial plaintiff > attorneys, who seize upon the negative publicity. > > It is widely acknowledged by legal experts that mass torts such as asbestos, > while still a relatively new phenomenon, have escalated to a crisis level and > may victimize those becoming sick in the future whom they purport to help. > Widespread litigation has driven companies to seek the counsel of economists > like Fred Dunbar. As expert witnesses, economists testify on behalf of > manufacturers, who Dr. Dunbar says have their backs against the wall in a > 'broken' tort system. He believes that economic testimony allows jurors and > judges to put difficult tort cases through the checks and balances needed to > arrive at a fair decision. > > Stemming courtroom hyperbole with objective analysis helps to bring perspective > back into the cases. " Aggressive plaintiffs can bring any company to its > knees by congesting the system with large numbers of tort actions. It's our job > to see that any solutions arrived at are equitable to all involved, " Dr. Dunbar > says. > > Dunbar says the need for objective economic analysis in such cases is essential > to preserving the integrity of due process as guaranteed by the constitution, > regardless of private interest or negative public perception of a manufacturer. > The economist, ultimately, helps ensure fair hearings for those who are > targeted by damaging lawsuits or legislation that can be extremely complex and > subjective. > > He points to part of the Court's concluding statements in the Dow-Corning case: > " The United States' Constitution and the rules and laws governing the judicial > system, although they may not be perfect, were enacted to ensure that all > parties' due process rights are observed by the courts. " > > Dr. Dunbar holds a PhD in economics from Tufts University and is the chair of > NERA's mass torts/product liability practice. He, along with his colleagues, > blend economics, statistics, survey research, epidemiological modeling and > computer programming in order to estimate the number and dollar of future > claims as well as the effect of publicity and entrepreneurial activity by > plaintiff attorneys and the likely rate of filing among potential claimants. > The work of this group also helps troubled companies craft claims strategies > and provide the basis for testimony on claims forecasts in bankruptcy court. He > has co-authored with another NERA economist, Dr. , what many in > the industry consider the " textbook " on claims forecasting entitled Estimating > Future Claims- Case Studies from Mass Tort and Product Liability (1996). > > Call us if you are interested in speaking with Dr. Dunbar on his work as an > economist and NERA's experience overall in some of the most highly charged > court decisions in the nation. > > Contact Allan Ripp, 212-721-7468, arippnyc@..., or Elena Napravnik, > 212-721-9979, elena73@... both for National Economic Research > Associates > > MAKE YOUR OPINION COUNT - Click Here > > http://tbutton.prnewswire.com/prn/11690X21843055 > > SOURCE National Economic Research Associates > > CO: National Economic Research Associates > > ST: New York > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.